Pear Bio
7 known investors
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
BiotechDigital HealthMedical Devices
Founders & leadership
DR
Duleek RanatungainFounder
Investors · 7
Competitors · 4
by search overlapPear VC7 shared keywordsPear VC is a venture capital firm specializing in pre-seed and seed-stage investing, providing portfolio companies with support in recruiting, founder-led sales coaching, and fundraising. The firm is run by former founders and operators.
Pillar Biosciences6 shared keywordsPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Fore5 shared keywordsFore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.
Pearl Bio5 shared keywordsPearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.
Companies competing with Pear Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Pear Bio do?
- Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
- Who founded Pear Bio?
- Pear Bio was founded by Duleek Ranatunga.
- Who are Pear Bio's investors?
- Pear Bio's investors include Compound, Earlymarket, Fly Ventures, Hoxton Ventures, Octopus Ventures, SoftBank Investment Advisers’ Emerge Program, Wavemaker Three-Sixty Health.